Metastatic Colorectal Cancers Terminated Phase 2 Trials for Sunitinib (DB01268)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00961571Sunitinib and Capecitabine for First Line Colon CancerTreatment